Startups
TolerogenixX vision is to innovate Immunosuppression with its newly developed MIC Cell Treatments. MIC Cell Treatment is a curative ATMP approach to achieve a sustained regulation of the immune system in Transplant - and Autoimmune Disease Patients. TolerogenixX has been able to generate strong pre-clinical as well as clinical data in the indications of Transplantation and Autoimmune Diseases e.g. SLE since its foundation in 2016.
Overview
Location
Czechia, Prague
Employees
1-10
Total raised
$13.07M
Founded date
2016
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 6, 2023 | TolerogenixX Raises €7 Million in Series A Funding to Revolutionize Clinical Trials | Key Takeaways: TolerogenixX, a leading player in the clinical trials industry, has successfully raised €7 million in a recent Series A funding round. The funding will enable TolerogenixX to advance its groundbreaking patented technology, po... |
| May 26, 2017 | TolerogenixX Secures Seed Funding | TolerogenixX GmbH, a Heidelberg, Germany-based developer of a patented and clinically tested cell therapy technique for individualized immunosuppression in transplant patients, raised seed funding from High-Tech Gründerfonds (HTGF). The amo... |
| TolerogenixX | “TolerogenixX - The smart way to immune tolerance” |
Reviews 0
FAQ about TolerogenixX GmbH
When was TolerogenixX GmbH founded?
TolerogenixX GmbH was founded in 2016.
How much funding has TolerogenixX GmbH raised?
TolerogenixX GmbH has raised $13.07M in total across 1 funding round.
What has the press written about TolerogenixX GmbH?
Parsers VC has collected 4 articles mentioning TolerogenixX GmbH, among them “TolerogenixX Raises €7 Million in Series A Funding to Revolutionize Clinical Trials” (Jul 6, 2023) and “TolerogenixX Secures Seed Funding” (May 26, 2017).
Is TolerogenixX GmbH still active?
Yes, TolerogenixX GmbH is active; its latest activity on Parsers VC dates from Jul 6, 2023.